GLP-1 receptor agonist for blood sugar regulation and weight management. Sold as Ozempic®, Wegovy®, and Rybelsus®.
Peptigrity tracks Semaglutide across 219 shops with 238 independent lab tests and an average HPLC purity of 99.65%.
Approved Uses and Brands
Ozempic® — Weekly subcutaneous injection for type 2 diabetes management and cardiovascular risk reduction in high-risk patients. Wegovy® — Higher-dose weekly injection specifically approved for chronic weight management in adults with obesity or overweight with related conditions. Rybelsus® — The only oral daily tablet form, primarily for type 2 diabetes.
Key Benefits Clinical studies show impressive results:
Strong blood sugar control in type 2 diabetes Average weight loss of 10–15%+ of body weight (often more with Wegovy) Reduced risk of major cardiovascular events and benefits for kidney health
Common Side Effects Mostly gastrointestinal and often temporary:
Nausea
These usually improve over time. Rare but serious risks include pancreatitis or thyroid tumors (in animal studies), so it's not suitable for everyone. Semaglutide should always be used under medical supervision, combined with diet and exercise for best results.
Every submitted test helps the community verify purity across brands. Free, fast, independent.